Patents by Inventor Charles Weir

Charles Weir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8176038
    Abstract: The invention may be a method and apparatus of organizing pointers. The pointers may identify addresses where objects are stored. The pointers may be stored in arrays so that at least two key entries are required from an input device for determining a byte and comparing the byte with bytes representing elements of objects in a database. The invention may be embodied as a machine designed to carry out the method, or as a memory device that is capable of causing a computer to carry out the method.
    Type: Grant
    Filed: January 20, 2011
    Date of Patent: May 8, 2012
    Assignee: Zi Corporation of Canada, Inc.
    Inventors: Charles Weir, Tommy Wildenflycht
  • Patent number: 8161020
    Abstract: Keys on an input device are selected to input a first selection and a second selection to form a byte. The byte is compared to a first byte of identification codes in a database. Such a method may use identification codes to identify pointers that correspond to objects in the database, and the pointers may indicate the address in a database where desired objects are stored. The input device has a database, a processor and executable instructions. The executable instructions may cause the processor to carry out a method of providing the objects.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: April 17, 2012
    Assignee: Zi Corporation of Canada, Inc.
    Inventors: Charles Weir, Tommy Wildenflycht
  • Patent number: 7977464
    Abstract: There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human TNF?. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by TNF?.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: July 12, 2011
    Assignee: UCB Pharma S.A.
    Inventors: Diljeet Singh Athwal, Derek Thomas Brown, Andrew Neil Charles Weir, Andrew George Popplewell, Andrew Paul Chapman, David John King
  • Publication number: 20110161363
    Abstract: The invention may be a method and apparatus of organizing pointers. The pointers may identify addresses where objects are stored. The pointers may be stored in arrays so that at least two key entries are required from an input device for determining a byte and comparing the byte with bytes representing elements of objects in a database. The invention may be embodied as a machine designed to carry out the method, or as a memory device that is capable of causing a computer to carry out the method.
    Type: Application
    Filed: January 20, 2011
    Publication date: June 30, 2011
    Applicant: ZI CORPORATION OF CANADA, INC.
    Inventors: Charles WEIR, Tommy Wildenflycht
  • Patent number: 7890492
    Abstract: The invention may be a method of organizing pointers. The pointers may identify addresses where objects are stored. The pointers may be stored in arrays so that the pointers corresponding to the most recently selected objects are stored nearer to ends of the arrays than are the pointers corresponding to less recently selected objects. The invention may be embodied as a machine designed to carry out the method, or as a memory device that is capable of causing a computer to carry out the method.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: February 15, 2011
    Assignee: Zi Corporation of Canada, Inc.
    Inventors: Charles Weir, Tommy Wildenflycht
  • Patent number: 7718157
    Abstract: Targeted lipids and lipid particles are described which are assemblies of multipolar lipids, targeting molecules such as antibodies and polyanions. The lipids are of particular use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo.
    Type: Grant
    Filed: August 16, 2000
    Date of Patent: May 18, 2010
    Inventors: Terence Seward Baker, Andrew Neil Charles Weir, Catherine Fiona Catterall, Michael Anthony William Eaton, Timothy John Norman, David Parker
  • Patent number: 7531676
    Abstract: Bipolar lipids are described which are able to form complexes with polyanions. The lipids comprise a cationic head linked to a hydrophobic backbone and a hydrophilic tail and are capable of self assembly to form stable complexes in aqueous solutions. The lipids are of particular use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo.
    Type: Grant
    Filed: July 26, 2005
    Date of Patent: May 12, 2009
    Assignee: Celltech R & D Limited
    Inventors: Michael Anthony William Eaton, Timothy John Norman, David Parker, Terence Seward Baker, Andrew Neil Charles Weir, Catherine Fiona Catterall
  • Publication number: 20080269465
    Abstract: There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human TNF?. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by TNF?.
    Type: Application
    Filed: June 18, 2008
    Publication date: October 30, 2008
    Applicant: UCB PHARMA S.A.
    Inventors: DILJEET SINGH ATHWAL, DEREK THOMAS BROWN, ANDREW NEIL CHARLES WEIR, ANDREW GEORGE POPPLEWELL, ANDREW PAUL CHAPMAN, DAVID JOHN KING
  • Patent number: 7402662
    Abstract: There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human TNF?. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by TNF?.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: July 22, 2008
    Assignee: UCB Pharma S.A.
    Inventors: Dilijeet Singh Athwal, Derek Thomas Brown, Andrew Neil Charles Weir, Andrew George Popplewell, Andrew Paul Chapman, David John King
  • Publication number: 20080138054
    Abstract: A member for an electrical heating apparatus, the member comprising coupling means for structurally and electrically coupling one or more elements to the member. The invention further provides a cooperating element and an apparatus including one or more of the members and/or one or more of the elements. An electrical heater is also provided, the heater having a plurality of points for connecting to an electrical power supply.
    Type: Application
    Filed: November 26, 2007
    Publication date: June 12, 2008
    Applicant: D C Short Limited
    Inventor: David Charles Weir Short
  • Publication number: 20070199270
    Abstract: A finishing system insulation panel includes a primary insulation board, a covering suitable to provide an aesthetically pleasing surface and a film bonding the covering to the primary insulation board. The film is configured to substantially retard the flow of air, moisture, and gases.
    Type: Application
    Filed: December 30, 2006
    Publication date: August 30, 2007
    Inventors: Charles Weir, John Beason
  • Publication number: 20070157565
    Abstract: An apparatus stacks, compresses and packages compressible batts. The batts, once at least partially compressed, remain under compression during the stacking, compressing and packaging.
    Type: Application
    Filed: December 28, 2005
    Publication date: July 12, 2007
    Inventors: Weigang Qi, Charles Weir
  • Publication number: 20070142692
    Abstract: A method of refinishing a wall containing lead paint includes the steps of covering the wall with a series of barrier boards impermeable to lead dust, sealing joints between the barrier boards so as to prevent the passage of lead dust and installing finishing panels over the series of barrier boards. A lead abatement system is also provided including a series of barrier boards, joint tape and finishing panels.
    Type: Application
    Filed: December 21, 2005
    Publication date: June 21, 2007
    Inventors: Todd Hall, Charles Weir
  • Publication number: 20070141309
    Abstract: A method of adding an additional room to an existing building includes selecting an exterior wall to be a common wall between the existing building and the additional room, adding the additional room to the existing building along the common wall, removing exterior layers of the common wall to expose a core, and attaching an acoustic finishing system to the core.
    Type: Application
    Filed: December 30, 2006
    Publication date: June 21, 2007
    Inventor: Charles Weir
  • Publication number: 20070125011
    Abstract: An acoustical absorbing membrane that may be used in removable panel finishing systems is provided. The acoustic membrane may be formed of any sound transmission loss material that possesses sound-absorbing or sound-deadening qualities. Examples of suitable materials include foil, a foil-faced asphalt material, elastomeric materials, composite laminates, a polymer film, a composite material formed of an organic bonding material and one or more types of reinforcement fibers, a cement board, a gypsum board, a gypsum/WUCS board, a dense WUCS mat, a film formed of a fiberglass reinforced resin, and/or any dense polymeric material. In at least one exemplary embodiment, the acoustic membrane may be a film formed of a loaded polymer or copolymer, such as a copolymer of ethylene-vinyl acetate loaded with barium or CaCO3. The acoustic membrane may have a density of approximately 1 lb/ft2-3 lbs/ft2 and preferably has a thickness from about 1/16-? of an inch.
    Type: Application
    Filed: December 6, 2006
    Publication date: June 7, 2007
    Inventors: Charles Weir, Kevin Herreman
  • Publication number: 20070068101
    Abstract: An insulation finishing system includes a plurality of lineals fixed to a building structure. The lineal partitions define primary insulation cavities. A plurality of primary insulation panels are positioned within the primary insulation cavities. A plurality of lineal adapters are connected to the lineals. The lineal adapters define secondary insulation cavities. A plurality of finish insulation panels are positioned within the secondary insulation cavities. The primary insulation panels and the finish insulation panels define a gap between each other. A vapor retarder is disposed in the gap. The vapor retarder is configured to substantially reflect thermal energy or heat away from the gap. A plurality of trim pieces are connected to the lineal adapters.
    Type: Application
    Filed: October 17, 2006
    Publication date: March 29, 2007
    Inventors: Charles Weir, Matthew Brokaw
  • Publication number: 20070068104
    Abstract: An insulation finishing system includes a plurality of lineals fixed to a building structure. The lineals include lineal partitions which protrude from the building structure and which define primary insulation cavities. A plurality of primary insulation panels are positioned within the primary insulation cavities. A plurality of trim pieces fix the primary insulation panels within the primary insulation cavities. The primary insulation panels are provided with an interference fit with the lineal partitions.
    Type: Application
    Filed: October 17, 2006
    Publication date: March 29, 2007
    Inventors: Charles Weir, Matthew Brokaw
  • Patent number: 7186820
    Abstract: There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human TNF?. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by TNF?.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: March 6, 2007
    Assignee: UCB Celltech
    Inventors: Diljeet Singh Athwal, Derek Thomas Brown, Andrew Neil Charles Weir, Andrew George Popplewell, Andrew Paul Chapman, David John King
  • Publication number: 20060173807
    Abstract: The invention may be a method of organizing pointers. The pointers may identify addresses where objects are stored. The pointers may be stored in arrays so that the pointers corresponding to the most recently selected objects are stored nearer to ends of the arrays than are the pointers corresponding to less recently selected objects. The invention may be embodied as a machine designed to carry out the method, or as a memory device that is capable of causing a computer to carry out the method.
    Type: Application
    Filed: November 14, 2005
    Publication date: August 3, 2006
    Inventors: Charles Weir, Tommy Wildenflycht
  • Publication number: 20060136408
    Abstract: The invention may be embodied as a method of providing information. The information may be stored as objects in a database. Such a method may use identification codes to identify pointers, and the pointers may indicate the address in a database where desired objects are stored. The invention may also be embodied as a machine having an input device, a database, a processor and executable instructions. The executable instructions may cause the processor to carry out a method according to the invention.
    Type: Application
    Filed: November 14, 2005
    Publication date: June 22, 2006
    Inventors: Charles Weir, Tommy Wildenflycht